Post-acute COVID-19 Sequelae in Denmark

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Non-communicable DiseaseCOVID-19
Interventions
PROCEDURE

blood sample

Blood sample collected in the post-acute period (follow-up visit) will be analysed for biomarkers predictive for diseases related to and disease progression in various organ systems (e.g., cardiovascular, pulmonary, and renal systems), including e.g., Pro-BNP, NGAL, and interleukins.

OTHER

Online questionaire

The participants will complete an online questionnaire related to disease and health issues associated with COVID-19 and COVID-19 post-acute sequalae's and existing Non-Communicable Disease.

Trial Locations (1)

2650

RECRUITING

Copenhagen University Hospital, Amager and Hvidovre, Hvidovre

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER